Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 10 | 0 | 0 | 10 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 4 | 0 | 0 | 4 |
thioredoxin reductase | 43 | 0 | 0 | 43 |
USP1 protein, partial | 36 | 0 | 0 | 36 |
TDP1 protein | 63 | 0 | 0 | 63 |
vitamin D3 receptor isoform VDRA | 14 | 0 | 0 | 14 |
importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
flap endonuclease 1 | 14 | 0 | 0 | 14 |
serine/threonine-protein kinase PLK1 | 4 | 0 | 0 | 4 |
snurportin-1 | 4 | 0 | 0 | 4 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 7 | 0 | 0 | 7 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 17 | 0 | 0 | 17 |
urokinase-type plasminogen activator precursor | 8 | 0 | 0 | 8 |
plasminogen precursor | 8 | 0 | 0 | 8 |
urokinase plasminogen activator surface receptor precursor | 8 | 0 | 0 | 8 |
geminin | 57 | 0 | 0 | 57 |
DNA polymerase kappa isoform 1 | 17 | 0 | 0 | 17 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 4 |
Fatty acid-binding protein, intestinal | 0 | 2 | 1 | 3 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 2 | 4 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 5 | 0 | 0 | 5 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 22 | 0 | 0 | 22 |
Chain A, Cruzipain | 9 | 0 | 0 | 9 |
regulator of G-protein signaling 4 | 30 | 0 | 0 | 30 |
Platelet-activating factor receptor | 0 | 4 | 0 | 5 |
Inositol monophosphatase 1 | 14 | 0 | 0 | 14 |
Sodium-dependent noradrenaline transporter | 0 | 53 | 7 | 60 |
Sodium-dependent serotonin transporter | 0 | 47 | 7 | 54 |
Sodium-dependent dopamine transporter | 0 | 44 | 4 | 48 |
acetylcholinesterase | 26 | 0 | 0 | 26 |
pregnane X receptor | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 46 | 0 | 0 | 46 |
GLI family zinc finger 3 | 45 | 0 | 0 | 45 |
AR protein | 64 | 0 | 0 | 64 |
aldehyde dehydrogenase 1 family, member A1 | 26 | 0 | 0 | 26 |
thyroid stimulating hormone receptor | 29 | 0 | 0 | 29 |
estrogen receptor 2 (ER beta) | 29 | 0 | 0 | 29 |
nuclear receptor subfamily 1, group I, member 3 | 35 | 0 | 0 | 35 |
glucocorticoid receptor [Homo sapiens] | 50 | 0 | 0 | 50 |
retinoic acid nuclear receptor alpha variant 1 | 41 | 0 | 0 | 41 |
retinoid X nuclear receptor alpha | 33 | 0 | 0 | 33 |
estrogen-related nuclear receptor alpha | 57 | 0 | 0 | 57 |
estrogen nuclear receptor alpha | 69 | 0 | 0 | 69 |
67.9K protein | 15 | 0 | 0 | 15 |
peroxisome proliferator-activated receptor delta | 25 | 0 | 0 | 25 |
peroxisome proliferator activated receptor gamma | 36 | 0 | 0 | 36 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 24 | 0 | 0 | 24 |
aryl hydrocarbon receptor | 23 | 0 | 0 | 23 |
cellular tumor antigen p53 isoform a | 14 | 0 | 0 | 14 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 12 | 0 | 0 | 12 |
thyroid hormone receptor beta isoform a | 14 | 0 | 0 | 14 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 13 | 0 | 0 | 13 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 47 | 0 | 0 | 47 |
histone deacetylase 9 isoform 3 | 6 | 0 | 0 | 6 |
mitogen-activated protein kinase 1 | 21 | 0 | 0 | 21 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 42 | 0 | 0 | 42 |
nuclear receptor ROR-gamma isoform 1 | 26 | 0 | 0 | 26 |
survival motor neuron protein isoform d | 16 | 0 | 0 | 16 |
histone acetyltransferase KAT2A isoform 1 | 23 | 0 | 0 | 23 |
Voltage-dependent calcium channel gamma-2 subunit | 23 | 0 | 0 | 23 |
Cellular tumor antigen p53 | 47 | 0 | 0 | 47 |
Integrin beta-3 | 9 | 1 | 0 | 10 |
Integrin alpha-IIb | 9 | 1 | 0 | 10 |
Glutamate receptor 2 | 23 | 1 | 1 | 25 |
Nuclear receptor ROR-gamma | 10 | 1 | 1 | 12 |
TAR DNA-binding protein 43 | 9 | 0 | 0 | 9 |
ATPase family AAA domain-containing protein 5 | 21 | 0 | 0 | 21 |
Ataxin-2 | 39 | 0 | 0 | 39 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 4 | 4 |
arylsulfatase A | 31 | 0 | 0 | 31 |
IDH1 | 26 | 0 | 0 | 26 |
Histone H2A.x | 21 | 0 | 0 | 21 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
peripheral myelin protein 22 | 37 | 0 | 0 | 37 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 9 | 0 | 9 |
Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Avidin | 0 | 0 | 1 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 4 | 0 | 4 |
Insulin receptor | 0 | 0 | 0 | 1 |
Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 13 | 3 | 17 |
Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 3 | 0 | 3 |
Endoplasmin | 0 | 1 | 1 | 2 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 3 | 0 | 3 |
Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 11 | 1 | 15 |
Adenosine receptor A3 | 0 | 3 | 0 | 3 |
Adenosine receptor A2a | 0 | 7 | 6 | 16 |
Adenosine receptor A2b | 0 | 2 | 1 | 6 |
Adenosine receptor A2b | 0 | 5 | 2 | 9 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 9 | 4 | 18 |
Adenosine receptor A2a | 0 | 9 | 2 | 16 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 3 | 1 | 4 |
Adenosine kinase | 0 | 0 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
Adenosine kinase | 0 | 1 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
Adenosine transporter 1 | 0 | 0 | 0 | 1 |
glp-1 receptor, partial | 19 | 0 | 0 | 19 |
GLS protein | 34 | 0 | 0 | 34 |
euchromatic histone-lysine N-methyltransferase 2 | 62 | 0 | 0 | 62 |
thyroid stimulating hormone receptor | 25 | 0 | 0 | 25 |
ATP-binding cassette sub-family C member 3 | 0 | 62 | 0 | 62 |
Multidrug resistance-associated protein 4 | 0 | 62 | 0 | 62 |
Bile salt export pump | 0 | 91 | 0 | 91 |
Beta-2 adrenergic receptor | 0 | 23 | 15 | 39 |
Beta-1 adrenergic receptor | 0 | 24 | 12 | 36 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 10 | 10 | 20 |
Delta-type opioid receptor | 0 | 6 | 2 | 8 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 5 | 12 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 9 | 14 |
Canalicular multispecific organic anion transporter 1 | 0 | 61 | 0 | 61 |
ATP-dependent phosphofructokinase | 30 | 0 | 0 | 30 |
potassium voltage-gated channel subfamily H member 2 isoform d | 29 | 0 | 0 | 29 |
Microtubule-associated protein tau | 23 | 0 | 0 | 23 |
lamin isoform A-delta10 | 55 | 0 | 0 | 55 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 16 | 0 | 0 | 16 |
phosphopantetheinyl transferase | 22 | 0 | 0 | 22 |
hypoxia-inducible factor 1 alpha subunit | 18 | 0 | 0 | 18 |
SMAD family member 2 | 13 | 0 | 0 | 13 |
ATAD5 protein, partial | 29 | 0 | 0 | 29 |
Fumarate hydratase | 18 | 0 | 0 | 18 |
NFKB1 protein, partial | 13 | 0 | 0 | 13 |
PPM1D protein | 9 | 0 | 0 | 9 |
SMAD family member 3 | 13 | 0 | 0 | 13 |
Thrombopoietin | 13 | 0 | 0 | 13 |
caspase 7, apoptosis-related cysteine protease | 13 | 0 | 0 | 13 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 11 | 0 | 0 | 11 |
progesterone receptor | 33 | 0 | 0 | 33 |
EWS/FLI fusion protein | 33 | 0 | 0 | 33 |
farnesoid X nuclear receptor | 26 | 0 | 0 | 26 |
pregnane X nuclear receptor | 40 | 0 | 0 | 40 |
G | 24 | 0 | 0 | 24 |
cytochrome P450 2D6 | 40 | 0 | 0 | 40 |
polyprotein | 18 | 0 | 0 | 18 |
caspase-3 | 13 | 0 | 0 | 13 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 28 | 0 | 0 | 28 |
cytochrome P450 2D6 isoform 1 | 18 | 0 | 0 | 18 |
cytochrome P450 2C9 precursor | 9 | 0 | 0 | 9 |
D(1A) dopamine receptor | 30 | 0 | 0 | 30 |
chromobox protein homolog 1 | 33 | 0 | 0 | 33 |
heat shock protein beta-1 | 13 | 0 | 0 | 13 |
huntingtin isoform 2 | 13 | 0 | 0 | 13 |
serine/threonine-protein kinase mTOR isoform 1 | 21 | 0 | 0 | 21 |
cytochrome P450 3A4 isoform 1 | 22 | 0 | 0 | 22 |
muscarinic acetylcholine receptor M1 | 31 | 0 | 0 | 31 |
lethal factor (plasmid) | 17 | 0 | 0 | 17 |
Gamma-aminobutyric acid receptor subunit pi | 22 | 10 | 6 | 38 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 17 | 0 | 0 | 17 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 7 |
Solute carrier organic anion transporter family member 1A4 | 0 | 4 | 0 | 7 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 17 | 0 | 17 |
5-hydroxytryptamine receptor 4 | 0 | 44 | 0 | 44 |
Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
Interferon beta | 34 | 0 | 0 | 34 |
HLA class I histocompatibility antigen, B alpha chain | 24 | 0 | 0 | 24 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 5 | 0 | 5 |
ATP-dependent translocase ABCB1 | 0 | 7 | 0 | 7 |
Aldo-keto reductase family 1 member B1 | 0 | 41 | 0 | 41 |
Muscarinic acetylcholine receptor M2 | 0 | 34 | 6 | 46 |
Muscarinic acetylcholine receptor M4 | 0 | 34 | 4 | 42 |
ATP-dependent translocase ABCB1 | 0 | 28 | 2 | 46 |
Muscarinic acetylcholine receptor M5 | 0 | 36 | 3 | 43 |
Alpha-2A adrenergic receptor | 0 | 43 | 4 | 49 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Thyroid hormone receptor alpha | 0 | 3 | 3 | 6 |
Thyroid hormone receptor beta | 0 | 3 | 3 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 39 | 5 | 50 |
D(2) dopamine receptor | 0 | 34 | 5 | 46 |
Androgen receptor | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 22 | 10 | 6 | 38 |
Alpha-1B adrenergic receptor | 0 | 30 | 5 | 35 |
Lethal factor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 37 | 2 | 41 |
Thyroid hormone receptor beta | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 22 | 10 | 6 | 38 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 22 | 10 | 8 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 22 | 10 | 6 | 38 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 22 | 10 | 6 | 38 |
Muscarinic acetylcholine receptor M3 | 0 | 36 | 5 | 45 |
ATP-dependent translocase ABCB1 | 0 | 7 | 0 | 8 |
Substance-K receptor | 0 | 8 | 0 | 8 |
D(1A) dopamine receptor | 0 | 27 | 2 | 32 |
D(4) dopamine receptor | 0 | 18 | 2 | 25 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 22 | 10 | 6 | 38 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 22 | 10 | 6 | 38 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 23 | 2 | 25 |
Endothelin-1 receptor | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 43 | 2 | 47 |
5-hydroxytryptamine receptor 2C | 0 | 46 | 2 | 48 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 22 | 10 | 6 | 38 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 22 | 10 | 6 | 38 |
Lysine-specific demethylase 5A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 22 | 10 | 6 | 38 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 6 | 0 | 6 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 8 | 0 | 8 |
Mu-type opioid receptor | 0 | 16 | 5 | 21 |
D(3) dopamine receptor | 0 | 39 | 5 | 51 |
Sodium channel protein type 1 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 4 subunit alpha | 0 | 8 | 0 | 9 |
Squalene synthase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 9 | 2 | 11 |
Kappa-type opioid receptor | 0 | 11 | 2 | 13 |
5-hydroxytryptamine receptor 2B | 0 | 47 | 2 | 49 |
C-C chemokine receptor type 2 | 0 | 6 | 0 | 6 |
Melanocortin receptor 3 | 0 | 6 | 0 | 6 |
Alpha-1A adrenergic receptor | 0 | 32 | 6 | 38 |
Histamine H2 receptor | 20 | 3 | 2 | 30 |
D(1A) dopamine receptor | 16 | 2 | 0 | 18 |
5-hydroxytryptamine receptor 6 | 0 | 33 | 1 | 35 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 4 | 0 | 4 |
Spike glycoprotein | 31 | 3 | 4 | 38 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 22 | 11 | 8 | 41 |
Gamma-aminobutyric acid receptor subunit beta-3 | 22 | 10 | 6 | 38 |
Gamma-aminobutyric acid receptor subunit beta-2 | 22 | 10 | 8 | 40 |
Sodium channel protein type 7 subunit alpha | 0 | 7 | 0 | 7 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 17 | 0 | 17 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 48 | 1 | 49 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 17 | 0 | 17 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 20 | 0 | 21 |
Sodium channel protein type 5 subunit alpha | 0 | 16 | 0 | 16 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 12 | 0 | 12 |
Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
GABA theta subunit | 22 | 10 | 6 | 38 |
Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 24 | 0 | 0 | 24 |
Sodium channel protein type 2 subunit alpha | 0 | 8 | 0 | 8 |
Sigma non-opioid intracellular receptor 1 | 0 | 35 | 1 | 36 |
Gamma-aminobutyric acid receptor subunit epsilon | 22 | 10 | 6 | 38 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 9 | 0 | 9 |
Sodium channel protein type 11 subunit alpha | 0 | 6 | 0 | 6 |
Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 10 subunit alpha | 0 | 6 | 0 | 6 |
cytochrome P450 2C9, partial | 24 | 0 | 0 | 24 |
Chain A, HADH2 protein | 14 | 0 | 0 | 14 |
Chain B, HADH2 protein | 14 | 0 | 0 | 14 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 42 | 0 | 0 | 42 |
atrial natriuretic peptide receptor 2 precursor | 11 | 0 | 0 | 11 |
Solute carrier family 22 member 1 | 0 | 23 | 0 | 26 |
Albumin | 0 | 0 | 10 | 10 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 15 | 2 | 21 |
Muscarinic acetylcholine receptor M3 | 0 | 13 | 2 | 18 |
Muscarinic acetylcholine receptor M4 | 0 | 12 | 1 | 16 |
5-hydroxytryptamine receptor 2C | 0 | 18 | 0 | 18 |
Muscarinic acetylcholine receptor M5 | 0 | 12 | 1 | 16 |
Muscarinic acetylcholine receptor M2 | 0 | 15 | 2 | 21 |
Angiotensin-converting enzyme | 0 | 28 | 0 | 29 |
5-hydroxytryptamine receptor 2A | 0 | 20 | 0 | 20 |
Alpha-2C adrenergic receptor | 0 | 33 | 3 | 38 |
5-hydroxytryptamine receptor 1A | 0 | 40 | 4 | 45 |
D(1B) dopamine receptor | 0 | 6 | 1 | 10 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 7 |
Alpha-1D adrenergic receptor | 0 | 38 | 5 | 46 |
5-hydroxytryptamine receptor 1B | 0 | 32 | 0 | 32 |
5-hydroxytryptamine receptor 1D | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 1F | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 2B | 0 | 16 | 1 | 17 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 9 | 1 | 10 |
5-hydroxytryptamine receptor 7 | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 5A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 5B | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 30 | 4 | 36 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 7 | 0 | 13 | 0 | 13 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 5 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 3 | 7 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 22 | 0 | 22 |
5-hydroxytryptamine receptor 3B | 0 | 5 | 0 | 5 |
Histamine H3 receptor | 0 | 8 | 2 | 10 |
Chain A, Ferritin light chain | 12 | 0 | 0 | 12 |
Smad3 | 11 | 0 | 0 | 11 |
NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 6 | 6 | 12 |
Alpha-2B adrenergic receptor | 0 | 19 | 5 | 24 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 6 | 0 | 6 |
Alpha-2C adrenergic receptor | 0 | 19 | 5 | 24 |
Alpha-2A adrenergic receptor | 0 | 19 | 5 | 24 |
Alpha-1A adrenergic receptor | 0 | 16 | 6 | 27 |
Alpha-1B adrenergic receptor | 0 | 13 | 5 | 21 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
glucocerebrosidase | 15 | 0 | 0 | 15 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Bloom syndrome protein isoform 1 | 20 | 0 | 0 | 20 |
neuropeptide S receptor isoform A | 8 | 0 | 0 | 8 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
alpha-galactosidase | 4 | 0 | 0 | 4 |
cytochrome P450 2C19 precursor | 10 | 0 | 0 | 10 |
Cytochrome P450 3A4 | 0 | 18 | 0 | 22 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 4 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 2 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 7 | 0 | 0 | 7 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 19 | 0 | 0 | 19 |
lysosomal alpha-glucosidase preproprotein | 6 | 0 | 0 | 6 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 3 | 3 |
transcriptional regulator ERG isoform 3 | 5 | 0 | 0 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 3 | 3 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 12 | 5 | 17 |
Neuronal acetylcholine receptor subunit alpha-4 | 4 | 3 | 0 | 7 |
Neuronal acetylcholine receptor subunit beta-2 | 4 | 3 | 0 | 7 |
D | 0 | 15 | 0 | 15 |
Alpha-1D adrenergic receptor | 0 | 21 | 5 | 26 |
D(4) dopamine receptor | 0 | 11 | 0 | 11 |
Histamine H1 receptor | 0 | 6 | 3 | 10 |
5-hydroxytryptamine receptor 7 | 0 | 7 | 1 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 22 | 0 | 23 |
5-hydroxytryptamine receptor 3D | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 3C | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 12 | 0 | 12 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 24 | 0 | 0 | 24 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 7 | 0 | 0 | 7 |
hypothetical protein, conserved | 3 | 0 | 0 | 3 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 16 | 0 | 21 |
Carbonic anhydrase 2 | 0 | 17 | 1 | 23 |
Fatty acid-binding protein, liver | 0 | 5 | 0 | 5 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 9 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 7 | 1 | 8 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 5 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
Chain A, Beta-lactamase | 15 | 0 | 0 | 15 |
nonstructural protein 1 | 10 | 0 | 0 | 10 |
bromodomain adjacent to zinc finger domain 2B | 12 | 0 | 0 | 12 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 26 | 0 | 0 | 26 |
activating transcription factor 6 | 17 | 0 | 0 | 17 |
thyrotropin-releasing hormone receptor | 5 | 0 | 0 | 5 |
Caspase-7 | 6 | 0 | 0 | 6 |
Spike glycoprotein | 0 | 3 | 4 | 7 |
Replicase polyprotein 1ab | 0 | 3 | 4 | 7 |
caspase-3 | 6 | 0 | 0 | 6 |
ubiquitin-conjugating enzyme E2 N | 0 | 3 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 3 | 4 | 7 |
Polycomb protein EED | 0 | 2 | 0 | 2 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 4 | 4 | 8 |
Replicase polyprotein 1a | 0 | 3 | 4 | 7 |
Replicase polyprotein 1ab | 0 | 3 | 4 | 7 |
Replicase polyprotein 1ab | 0 | 6 | 4 | 10 |
Replicase polyprotein 1ab | 0 | 7 | 4 | 11 |
Glycine receptor subunit alpha-1 | 0 | 0 | 4 | 4 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 19 | 0 | 21 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 5 | 4 | 9 |
Histamine H4 receptor | 0 | 4 | 3 | 7 |
Heparanase | 0 | 0 | 2 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 7 | 11 |
Urease | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 1 | 2 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 5 | 0 | 0 | 5 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 3 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 2 | 4 |
Muscarinic acetylcholine receptor | 0 | 3 | 2 | 6 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
P53 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 14 | 0 | 0 | 14 |
hemoglobin subunit beta | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 16 | 0 | 0 | 16 |
muscleblind-like protein 1 isoform 1 | 8 | 0 | 0 | 8 |
Bile salt export pump | 0 | 16 | 0 | 16 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 7 | 0 | 0 | 7 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 7 | 0 | 9 |
Solute carrier organic anion transporter family member 1B1 | 0 | 10 | 0 | 13 |
Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 4 | 0 | 9 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 21 | 0 | 21 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 5 | 0 | 6 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 8 | 0 | 0 | 8 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 4 | 0 | 4 |
Cholinesterase | 0 | 7 | 0 | 7 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 9 | 0 | 10 |
Amine oxidase [flavin-containing] B | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 8 | 1 | 10 |
Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
Serine/threonine-protein kinase mTOR | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 2 |
Chitotriosidase-1 | 0 | 2 | 0 | 2 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 3 | 4 |
Endochitinase B1 | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 8 | 1 | 10 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Luciferase | 14 | 0 | 0 | 14 |
15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
Cruzipain | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 7 | 7 |
NEDD8-activating enzyme E1 regulatory subunit | 0 | 1 | 1 | 2 |
NEDD8-activating enzyme E1 catalytic subunit | 0 | 0 | 1 | 1 |
DNA polymerase kappa | 0 | 1 | 0 | 1 |
DNA polymerase iota | 0 | 1 | 0 | 1 |
DNA polymerase eta | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 5 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 3 |
transient receptor potential cation channel subfamily V member 1 | 3 | 0 | 0 | 3 |
Prothrombin | 0 | 2 | 1 | 3 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 5 | 1 | 6 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 1 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Beta-lactamase TEM | 0 | 2 | 0 | 3 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Beta-lactamase | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 3 |
GALC protein | 4 | 0 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 8 | 0 | 9 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
Vpr | 4 | 0 | 0 | 4 |
Major prion protein | 0 | 0 | 4 | 4 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Cytochrome P450 2C9 | 0 | 20 | 0 | 21 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 2 | 0 | 2 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 7 | 0 | 10 |
Carbonic anhydrase 3 | 0 | 7 | 0 | 8 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 10 | 0 | 13 |
Carbonic anhydrase 6 | 0 | 9 | 0 | 12 |
Carbonic anhydrase 5A, mitochondrial | 0 | 11 | 1 | 15 |
Carbonic anhydrase 7 | 0 | 8 | 0 | 11 |
Carbonic anhydrase 9 | 0 | 11 | 0 | 15 |
Carbonic anhydrase 13 | 0 | 5 | 0 | 6 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 6 | 0 | 9 |
Carbonic anhydrase 5B, mitochondrial | 0 | 9 | 0 | 12 |
endonuclease IV | 6 | 0 | 0 | 6 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
Alpha-synuclein | 3 | 0 | 0 | 3 |
Glutathione reductase | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 7 | 0 | 0 | 7 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 2 | 3 | 0 | 5 |
Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 8 | 5 | 13 |
Translocator protein | 0 | 4 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 8 | 4 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 8 | 4 | 12 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 7 | 5 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 7 | 4 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 7 | 4 | 11 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 4 | 0 | 4 |
ras-related protein Rab-9A | 9 | 0 | 0 | 9 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Albumin | 0 | 4 | 8 | 13 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 3 | 1 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 4 | 1 | 5 |
Cytochrome P450 2D6 | 0 | 15 | 1 | 17 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 6 | 0 | 6 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 14 | 0 | 14 |
D(2) dopamine receptor | 0 | 6 | 0 | 6 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 3 | 0 | 4 | 0 | 4 |
D(1B) dopamine receptor | 0 | 10 | 0 | 10 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 4 | 0 | 4 |
Adenylate cyclase type 4 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
Trypanothione reductase | 0 | 6 | 0 | 6 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 2 | 8 |
Adenylate cyclase type 8 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 3 | 0 | 3 |
Proteasome subunit alpha type-6 | 0 | 0 | 2 | 3 |
Calmodulin | 0 | 1 | 3 | 4 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 2 | 8 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 2 | 8 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 2 | 8 |
Adenylate cyclase type 6 | 0 | 4 | 0 | 4 |
Adenylate cyclase type 5 | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 2 | 8 |
Adenylyl cyclase 7 | 0 | 4 | 0 | 4 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 2 | 8 |
D | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 2 | 8 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 5 | 0 | 5 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 3 | 0 | 3 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 5 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 6 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 4 | 0 | 5 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 5 | 0 | 6 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 5 | 0 | 6 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 8 | 1 | 10 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 7 | 0 | 8 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 6 | 0 | 7 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 7 | 0 | 8 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 3 | 3 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 5 | 0 | 6 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 7 | 0 | 8 |
Nischarin | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 8 | 1 | 10 |
Beta-1 adrenergic receptor | 0 | 9 | 3 | 14 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 5 | 1 | 6 |
Sodium-dependent serotonin transporter | 0 | 15 | 1 | 17 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Transporter | 0 | 4 | 0 | 4 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Transporter | 0 | 10 | 0 | 10 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 6 | 0 | 6 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
Tryptophan 5-hydroxylase 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 6 | 2 | 8 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 6 | 4 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 6 | 0 | 6 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 7 | 1 | 8 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 6 | 2 | 8 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 6 | 1 | 7 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 6 | 0 | 6 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Thymidine kinase 2 | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 0 | 0 | 1 |
AAA family ATPase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 1 | 2 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 1 | 2 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 1 | 2 |
PAX8 | 0 | 0 | 0 | 1 |
STAT3, partial | 0 | 1 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 6 | 0 | 0 | 6 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 3 | 0 | 3 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
pyruvate kinase | 1 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
LacZ protein (plasmid) | 0 | 0 | 1 | 1 |
beta-2 adrenergic receptor | 4 | 0 | 0 | 4 |
type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 2 | 0 | 2 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 2 | 0 | 2 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
polypyrimidine tract-binding protein 1 isoform a | 1 | 0 | 0 | 1 |
apelin receptor | 0 | 2 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 2 |
Carbamate kinase | 0 | 1 | 0 | 1 |
Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
Aldehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 2 | 0 | 3 |
C-C chemokine receptor type 5 | 0 | 4 | 0 | 4 |
Gasdermin-D | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
Monoglyceride lipase | 0 | 2 | 0 | 2 |
Gasdermin-D | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 1 | 1 | 2 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor 4 | 0 | 1 | 1 | 2 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 4 |
Cannabinoid receptor 2 | 0 | 2 | 1 | 4 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 1 | 2 |
N-arachidonyl glycine receptor | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Lysophosphatidylserine lipase ABHD12 | 0 | 1 | 0 | 1 |
Monoacylglycerol lipase ABHD6 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
G-protein coupled receptor 55 | 0 | 1 | 1 | 2 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 4 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Chain A, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
Chain B, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase delta catalytic subunit | 0 | 1 | 0 | 1 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 5 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 2 | 3 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
Histone deacetylase 8 | 0 | 3 | 0 | 3 |
Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 3 | 0 | 3 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 5 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
Mu-type opioid receptor | 0 | 7 | 0 | 7 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 4 | 0 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Protease | 0 | 3 | 0 | 3 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member C3 | 0 | 3 | 0 | 3 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 3 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Parkin | 3 | 0 | 0 | 3 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 3 | 1 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 5 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 3 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 3 | 4 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 0 | 4 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | 0 | 0 | 2 | 2 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | 0 | 0 | 2 | 2 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | 0 | 0 | 2 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 0 | 2 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 6 | 2 | 13 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
Aurora kinase A | 0 | 1 | 0 | 1 |
Dual specificity protein kinase TTK | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 5 | 0 | 5 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Inner centromere protein | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
voltage-dependent T-type calcium channel subunit alpha-1H isoform a | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 7 | 0 | 8 |
Cholinesterase | 0 | 6 | 1 | 8 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
MecA | 0 | 1 | 0 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Quinolone resistance protein NorA | 0 | 2 | 0 | 3 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 2 | 0 | 2 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 2 | 0 | 2 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 2 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-casein | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Chloroquine resistance transporter | 0 | 2 | 0 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 2 | 0 | 2 |
Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
Coagulation factor X | 0 | 2 | 0 | 2 |
Coagulation factor XII | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit epsilon | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Retina-specific copper amine oxidase | 0 | 1 | 0 | 1 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 2 | 0 | 2 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 5 isoform 1 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
Endoglycoceramidase II | 0 | 0 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Sphingosine kinase 2 | 0 | 1 | 0 | 1 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Sphingosine 1-phosphate receptor 2 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 4 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 1 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 3 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, ykoF | 0 | 0 | 1 | 1 |
Chain B, ykoF | 0 | 0 | 1 | 1 |
Chain A, ThiT | 0 | 0 | 1 | 1 |
Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
Transketolase | 0 | 0 | 1 | 1 |
Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
ClpP | 1 | 0 | 0 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |